OLMESARTAN-AMLODIPIN Mepha cpr pell 40/5mg 98 pce
7680661030047
CH-66103
C09DB02
02.07.2.
Reimbursement limitations:
OLMEAMLOMEPH
Le traitement combiné de OLMESARTAN-AMLODIPIN MEPHA et d'un antagoniste du calcium I.T. 02.06. et/ou d'un …
1 / 3
google
Details
- Product number
- 6610302
- CPT
- -
- Packaging group
- 98
- Unit
- Tablette(n)
- Composition
- olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas, cellulosum microcristallinum, lactosum monohydricum 24.6 mg, crospovidonum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto.
Articles (1)
Olmesartan-Amlodipin-Mepha 40 mg/5 mg, Filmtabletten
Filmtabletten
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
24.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.42 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 83.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2017
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66103
- Drug name
- Olmesartan-Amodipin-Mepha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C09DB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/12/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OLMESARTAN-AMLODIPIN Mepha cpr pell 40/5mg 98 pce
- Description (DE)
- OLMESARTAN-AMLODIPIN Mepha Filmtabl 40/5mg 98 Stk
- Market launch
- 07/12/2016
- Narcotic (BTM)
- No